Presentation SCAI 2018 Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement Presenter: Sahil Khera April 28, 2018 REGISTER for free or LOG IN to view this content Structural Heart Aortic Valve Presentation SCAI 2018 Up Next Presentation EAS 2018 LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis Presenter: Brian A. Ference May 07, 2018 More slides + Presentation EAS 2018 Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial Presenter: Michelle L. O’Donoghue May 07, 2018 Presentation Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US May 11, 2018 We Recommend
Presentation EAS 2018 LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis Presenter: Brian A. Ference May 07, 2018
Presentation EAS 2018 Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial Presenter: Michelle L. O’Donoghue May 07, 2018
Presentation Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US May 11, 2018